# ElastiMed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/elastimed

- Industry: Medical Devices & Equipment
- Headquarters: Yokne'am Illit, Israel
- Website: www.elastimed.com
- Total disclosed funding: $1M
- Latest round: Seed (Sep 24, 2017)
- Investors on record: 3

## About

ElastiMed Ltd. develops innovative wearable devices utilizing active dynamic compression technology to provide clinical-grade therapy, enhancing treatment for users requiring compression therapy.ElastiMed Ltd. was founded in 2015 in Yokne'am Illit, Israel, focusing on wearable devices for compression therapy. The company has engaged in 5 deals, with its most recent funding round occurring in September 2020. The firm raised USD 0.60 mn in venture funding from unspecified investors. The company's CEO and founder is Omer Zelka, who has a history of leadership in developing advanced medical technology.ElastiMed specializes in innovative wearable devices that incorporate active dynamic compression technology for clinical-grade therapy. Their main product features straps made from Electroactive Polymers (EAPs) that provide adjustable compression to treat various medical conditions effectively. The device is designed with comfort and ease of use in mind, allowing users to maintain arm motion while receiving treatment. This approach promotes patient compliance and enhances treatment efficacy. The primary end users include individuals requiring compression therapy, such as those with venous insufficiency or post-surgical recovery needs. ElastiMed's products cater to healthcare markets across Europe and North America, providing a blend of advanced medical technology with user-friendly design.ElastiMed generates revenue through direct sales of its flagship compression therapy devices, marketed to both healthcare providers and direct consumers. The company employs a B2B model, partnering with hospitals, rehabilitation centers, and clinics, while also engaging in direct-to-consumer sales through specialized medical equipment retailers. Customers are offered subscription-based services via a mobile app that provides ongoing care and personalized treatment recommendations, ensuring sustained engagement with the product. The pricing structure varies depending on device specifications and associated services, reflecting the advanced technology and clinical applications of their offerings.In September 2020, ElastiMed Ltd. raised USD 0.60 mn in venture funding, which will be utilized to support the development of upcoming products and expand into new markets. The company is focused on releasing additional compression therapy devices in the near future, while also targeting expansion into European and North American healthcare markets by the end of 2023.

## Funding rounds

- Seed, Sep 24, 2017, $1M — Trendlines Group, Pix Vine Capital, Israel Innovation Authority

## Investors

- Trendlines Group (https://capitalatlas.ai/funds/trendlines-group) — Seed
- Pix Vine Capital (https://capitalatlas.ai/funds/pix-vine-capital) — Seed
- Israel Innovation Authority — Seed